| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Prasad Devarajan | Q63144077 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 203-212 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Contributions to Nephrology | Q15755655 |
| P1476 | title | Emerging biomarkers of acute kidney injury | |
| P478 | volume | 156 |
| Q46785949 | A case of acute kidney injury due to complex, partial, multifocal ureteral strictures |
| Q89683877 | A long journey for acute kidney injury biomarkers |
| Q53575290 | A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis. |
| Q45326336 | A rapid plasma neutrophil gelatinase-associated lipocalin assay for diagnosis of acute pyelonephritis in infants with acute febrile urinary tract infections: a preliminary study |
| Q38664521 | Acute Kidney Injury Recognition and Management: A Review of the Literature and Current Evidence |
| Q82969406 | Acute kidney injury in children |
| Q37088280 | Acute kidney injury in the ICU: time has come for an early biomarker kit! |
| Q42120038 | Acute kidney injury in the intensive care unit: current trends in incidence and outcome |
| Q38595498 | Analyses of acute kidney injury biomarkers by ultra-high performance liquid chromatography with mass spectrometry |
| Q59321551 | Assessment of biochemical markers in the early post-burn period for predicting acute kidney injury and mortality in patients with major burn injury: comparison of serum creatinine, serum cystatin-C, plasma and urine neutrophil gelatinase-associated l |
| Q43217443 | Association of interleukin-18 gene polymorphisms with calcium oxalate kidney stone disease |
| Q37177159 | Association of neutrophil gelatinase associated lipocalin and cystatin-C with kidney function in children with nephrotic syndrome. |
| Q35154205 | Baseline values of candidate urine acute kidney injury biomarkers vary by gestational age in premature infants |
| Q38022745 | Biomarkers for early diagnosis of AKI in the ICU: ready for prime time use at the bedside? |
| Q39791593 | Biomarkers for the early detection of acute kidney injury |
| Q38836197 | Biomarkers in acute kidney injury - pathophysiological basis and clinical performance |
| Q38058688 | Biomarkers of acute kidney injury in neonatal encephalopathy |
| Q37100558 | Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia |
| Q57127462 | Comparison of urine neutrophil gelatinase-associated lipocalin and interleukin-18 in prediction of acute kidney injury in adults |
| Q47172818 | Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). |
| Q37077323 | Defining acute kidney injury: what is the most appropriate metric? |
| Q37556084 | Development and Validation of a Risk Score for Prediction of Acute Kidney Injury in Patients With Acute Decompensated Heart Failure: A Prospective Cohort Study in China |
| Q33754768 | Development and standardization of a furosemide stress test to predict the severity of acute kidney injury |
| Q37165221 | Dialysis and pediatric acute kidney injury: choice of renal support modality |
| Q37612750 | Dynamic Changes of Plasma Neutrophil Gelatinase-Associated Lipocalin Predicted Mortality in Critically Ill Patients with Systemic Inflammatory Response Syndrome |
| Q35934780 | Early lipid changes in acute kidney injury using SWATH lipidomics coupled with MALDI tissue imaging. |
| Q37010079 | Emerging urinary biomarkers in the diagnosis of acute kidney injury |
| Q98188972 | Evaluation of renal injury in children with uncorrected CHDs with significant shunt using urinary neutrophil gelatinase-associated lipocalin |
| Q33554447 | Glutamyl aminopeptidase in microvesicular and exosomal fractions of urine is related with renal dysfunction in cisplatin-treated rats. |
| Q37088301 | Ideal determinants for the initiation of renal replacement therapy: timing, metabolic threshold or fluid balance? |
| Q34461417 | Importance of neutrophil gelatinase-associated lipocalin in differential diagnosis of acute and chronic renal failure |
| Q51546598 | In situ assembly, regeneration and plasmonic immunosensing of a Au nanorod monolayer in a closed-surface flow channel. |
| Q46595284 | Induction of proapoptotic Daxx following ischemic acute kidney injury |
| Q35930950 | Intra-amniotic infection upregulates neutrophil gelatinase-associated lipocalin (NGAL) expression at the maternal-fetal interface at term: implications for infection-related preterm birth |
| Q42098845 | Ischemic preconditioning attenuates lipid peroxidation and apoptosis in the cecal ligation and puncture model of sepsis |
| Q91166011 | Laboratory Predictors of Contrast-Induced Nephropathy After Neurointervention: A Prospective 3-Year Observational Study |
| Q35196165 | Levels of protein C and soluble thrombomodulin in critically ill patients with acute kidney injury: a multicenter prospective observational study |
| Q47271595 | Lipopolysaccharide-Induced Acute Kidney Injury Is Dependent on an IL-18 Receptor Signaling Pathway |
| Q41269792 | Low-dose carvedilol protects against acute septic renal injury in rats during the early and late phases |
| Q36723313 | Methodological issues in current practice may lead to bias in the development of biomarker combinations for predicting acute kidney injury. |
| Q37000846 | N-GAL: diagnosing AKI as soon as possible |
| Q98158901 | NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AS AN EARLY BIOMARKER OF ACUTE KIDNEY INJURY IN NEWBORNS |
| Q81305644 | NGAL is an early predictive biomarker of contrast-induced nephropathy in children |
| Q37543196 | NGAL: a biomarker of acute kidney injury and other systemic conditions. |
| Q28074360 | Neutrophil Gelatinase Associated Lipocalin (NGAL) as a Biomarker. Does It Apply in Abdominal Aortic Aneurysms? A Review of Literature |
| Q38160639 | Neutrophil gelatinase associated lipocalin in acute kidney injury |
| Q36103565 | Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q45968140 | Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of cardiac surgery associated acute kidney injury. |
| Q44005921 | Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention. |
| Q37196895 | Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease |
| Q60975297 | Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis |
| Q44008816 | Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography |
| Q99411575 | Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans |
| Q85476227 | Neutrophil gelatinase-associated lipocalin is a sensitive biomarker for the early diagnosis of acute rejection after living-donor kidney transplantation |
| Q33945154 | Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury |
| Q37151919 | Neutrophil gelatinase-associated lipocalin: new paths for an old shuttle. |
| Q26824112 | Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications |
| Q37897225 | New biomarkers for acute renal injury |
| Q35048051 | New biomarkers of acute kidney injury and the cardio-renal syndrome |
| Q38094124 | Nitric oxide and its metabolites in the critical phase of illness: rapid biomarkers in the making |
| Q84474026 | Novel biomarkers of acute kidney toxicity |
| Q36768728 | Performance of urinary and gene expression biomarkers in detecting the nephrotoxic effects of melamine and cyanuric acid following diverse scenarios of co-exposure |
| Q89395824 | Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) - Early Biomarker for Acute Kidney Injury in Critically Ill Patients |
| Q34485410 | Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients |
| Q36465429 | Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study |
| Q35128552 | Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial |
| Q34626597 | Proteomic analysis of acute kidney injury: biomarkers to mechanisms |
| Q27305109 | Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat |
| Q33308859 | Proteomics for biomarker discovery in acute kidney injury |
| Q27320594 | Proximal tubule-derived colony stimulating factor-1 mediates polarization of renal macrophages and dendritic cells, and recovery in acute kidney injury |
| Q35983503 | Referral patterns and outcomes in noncritically ill patients with hospital-acquired acute kidney injury |
| Q38426778 | Renal angina: concept and development of pretest probability assessment in acute kidney injury |
| Q47134540 | Role of Urinary Neutrophil Gelatinase-associated Lipocalin as a Biomarker of Acute Kidney Injury in Patients with Circulatory Shock |
| Q36622423 | Role of new biomarkers: functional and structural damage |
| Q37130020 | Role of plasma neutrophil gelatinase-associated lipocalin as an emerging biomarker of acute renal failure following kidney transplantation and its correlation with plasma creatinine |
| Q21195747 | Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments |
| Q41081239 | Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney F |
| Q33729541 | Serum cystatin C is a sensitive early marker for changes in the glomerular filtration rate in patients undergoing laparoscopic surgery |
| Q30438245 | Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock |
| Q51072091 | Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease. |
| Q80565263 | The early biomarker of acute kidney injury: in search of the Holy Grail |
| Q55113956 | The effects of dexmedetomidine on secondary acute lung and kidney injuries in the rat model of intra-abdominal sepsis. |
| Q40964225 | The effects of prolonged CO2 insufflation on kidney function in a rat pneumoperitoneum model |
| Q37268203 | The future of pediatric acute kidney injury management--biomarkers |
| Q90470171 | The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis |
| Q36987909 | The role of neutrophil gelatinase-associated lipocalin in predicting acute kidney injury in patients undergoing off-pump coronary artery bypass graft: A pilot study |
| Q34346928 | The use of targeted biomarkers for chronic kidney disease |
| Q37252706 | Treatment of acute kidney injury in children: from conservative management to renal replacement therapy |
| Q45187926 | Urinary MMP-9/NGAL complex in children with acute cystitis |
| Q36528462 | Urinary NGAL Ratio Is Not a Sensitive Biomarker for Monitoring Acute Tubular Injury in Kidney Transplant Patients: NGAL and ATI in Renal Transplant Patients |
| Q34336198 | Urinary aminopeptidase activities as early and predictive biomarkers of renal dysfunction in cisplatin-treated rats |
| Q33338020 | Urinary aprotinin as a predictor of acute kidney injury after cardiac surgery in children receiving aprotinin therapy |
| Q43067029 | Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury |
| Q56774884 | Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study |
| Q36243377 | Urinary exosomal activating transcriptional factor 3 as the early diagnostic biomarker for sepsis-induced acute kidney injury |
| Q38575134 | Urinary neutrophil gelatinase-associated lipocalin for diagnosis and estimating activity in lupus nephritis: a meta-analysis |
| Q46160566 | Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons |
| Q44114578 | Urinary neutrophil gelatinase-associated lipocalin predicts graft loss after acute kidney injury in kidney transplant. |
| Q42182524 | Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria |
| Q24654092 | Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study |
| Q89496057 | Using Score for Neonatal Acute Physiology Perinatal Extension II (SNAPPE II) in Neonates with Acute Kidney Injury |
| Q42362215 | Value of plasma neutrophil gelatinase-associated lipocalin (NGAL) in distinguishing between acute kidney injury (AKI) and chronic kidney disease (CKD). |
Search more.